Additionally, microglia-specific knockout of a molecule in the NF-κB inflammatory pathway, and the expansion of neuroprotective microglia via CSF1R stimulation, have both been reported to reduce CNS inflammation in the EAE MS model (61, 62). This evidence concerns the gene NFKB1 and myeloid sarcoma.